Koers Aeolus Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2015 | 3,11 mln. 2,86 mln. | Omzet 2016 | 2,08 mln. 1,91 mln. | Marktkapitalisatie | 28,9 mln. 26,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2016 | -3 mln. -2,76 mln. | EV/omzet 2015 | 10,8 x |
Nettoschuld 2015 | 908K 834K | Nettoliquiditeiten 2016 | 3,16 mln. 2,9 mln. | EV/omzet 2016 | 12,4 x |
K/w-verhouding 2015 |
-12
x | K/w-verhouding 2016 |
-4,67
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 01-06-05 |
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 08-05-13 |
John Clerici
BRD | Director/Board Member | 54 | 08-05-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,18 mld. | |
+1,00% | 42,11 mld. | |
+50,47% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+13,68% | 26,09 mld. | |
-22,99% | 18,71 mld. | |
+8,22% | 13,26 mld. | |
+32,41% | 12,32 mld. | |
-1,62% | 11,99 mld. |
- Beurs
- Aandelen
- Koers AOLS
- Koers